A more useful conversation than “cure” versus “control”
People living with type 2 diabetes deserve more than a conversation limited to “manage this forever” or, at the other extreme, “reverse it quickly.” A better conversation is about remission: a measurable clinical outcome that may be achievable for some people through an individualized, sustained approach to metabolic health.
That distinction matters. The word cure suggests that a condition has disappeared permanently and needs no further attention. Type 2 diabetes does not work that way. Blood glucose can improve dramatically, sometimes to below the diagnostic range, but the underlying tendency toward dysglycemia can return. Weight regain, illness, life changes, medication changes, and the progressive nature of metabolic disease can all affect future risk. Remission is hopeful and meaningful—but it should be described honestly.
What does type 2 diabetes remission mean?
An international expert consensus convened by the American Diabetes Association proposed a clear working definition: an HbA1c below 6.5% at least three months after stopping glucose-lowering medication. HbA1c is a laboratory measure that estimates average blood glucose over roughly the preceding two to three months.
This definition does not reduce a person to one lab value. It provides a consistent way for clinicians, researchers, and patients to discuss outcomes. It also reinforces two important facts. First, remission is not diagnosed while a person is using glucose-lowering medication, because the medication itself may be responsible for the improved value. Second, remission requires ongoing observation. The consensus report recommends continued monitoring because recurrence is possible and complications screening remains important.
Remission is not a promise that diabetes has disappeared forever. It is a clinically meaningful improvement that deserves to be measured, supported, and monitored.
Why put remission on the table at all?
For years, type 2 diabetes care has often focused on lowering glucose after it rises. That work matters: glucose management can reduce symptoms and lower the risk of complications. But a clinical model that considers remission also asks whether the conditions driving insulin resistance, excess liver and pancreatic fat in some individuals, inactivity, disrupted sleep, food insecurity, stress, and other metabolic pressures can be addressed over time.
Research has shown that intensive lifestyle interventions can produce remission in some participants, especially earlier in the course of type 2 diabetes. In the DiRECT primary-care trial, a structured low-calorie weight-management program delivered remission for a substantial proportion of participants at one year and two years, although maintaining weight loss was strongly associated with maintaining remission. That is not a universal prescription, nor does it mean every person should use meal replacements or a very-low-calorie approach. It does show that metabolic improvement can be more than theoretical when care is structured, adequately supported, and sustained.
The American Diabetes Association also emphasizes that nutrition plans should be individualized and durable. There is no single eating pattern that works best for everyone; preferences, culture, budget, cooking time, medical conditions, and household needs all matter. A plan that cannot be lived with is unlikely to deliver lasting benefit.
Remission should expand choices—not create pressure
There is a risk in making remission the only definition of success. Someone may lower their HbA1c, reduce medication burden under clinical supervision, improve blood pressure, gain strength, sleep better, or prevent complications without meeting formal remission criteria. Those outcomes are real progress.
There is also a risk in implying that people who do not reach remission have failed. Type 2 diabetes is influenced by biology, duration of disease, access to care, medication effects, stress, food environments, and social circumstances. The right goal is not to assign blame. It is to make high-quality, person-centered care available and to pursue the best possible outcome for each individual.
For some people, medication will remain essential. Others may be able to reduce or discontinue glucose-lowering medication with clinician guidance after sustained lifestyle and metabolic changes. Some will pursue metabolic surgery, anti-obesity medication, or other clinical options. These paths are not moral categories. They are decisions to be made with a qualified care team, using the best available evidence and the person’s own goals.
What a remission-oriented plan can include
A responsible plan commonly addresses more than food. It may include individualized nutrition support; regular movement that builds both aerobic fitness and strength; sleep and stress management; tobacco and alcohol risk assessment; medication review; glucose monitoring; and support for barriers such as cost, transportation, caregiving, or mental health needs. The mix differs from person to person.
The goal is not a short-term challenge or a dramatic headline. It is a durable set of conditions that makes better metabolic health more likely. That is why careful follow-up remains part of remission care. HbA1c, blood pressure, cholesterol, kidney health, eye care, and foot care do not become irrelevant simply because glucose has improved.
A better standard for diabetes communication
Articles, programs, and clinicians should be precise about what they mean when they use the word reversal. If the claim is remission, the standard should be transparent: what measure was used, whether glucose-lowering medication was stopped, how long the outcome lasted, and how people were supported. Avoiding exaggerated promises protects patients and improves trust.
Diabetes Reversal Group believes type 2 diabetes care is strongest when it addresses the whole person—food, movement, sleep, stress, support systems, and ongoing clinical monitoring. For some people, clinician-directed medication is an important part of that plan; for everyone, lasting health requires more than a prescription alone.
Source note: This article was prompted by the American College of Lifestyle Medicine’s call to advance remission as a clinical goal.
Do not start, stop, or change diabetes medication without guidance from the clinician managing your care.